CN105919942A - 一种地美硝唑可溶性粉及其制备方法 - Google Patents
一种地美硝唑可溶性粉及其制备方法 Download PDFInfo
- Publication number
- CN105919942A CN105919942A CN201610529739.0A CN201610529739A CN105919942A CN 105919942 A CN105919942 A CN 105919942A CN 201610529739 A CN201610529739 A CN 201610529739A CN 105919942 A CN105919942 A CN 105919942A
- Authority
- CN
- China
- Prior art keywords
- parts
- dimetridazole
- soluble powder
- dimetridazoles
- pvp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IBXPYPUJPLLOIN-UHFFFAOYSA-N dimetridazole Chemical compound CC1=NC=C(N(=O)=O)N1C IBXPYPUJPLLOIN-UHFFFAOYSA-N 0.000 title claims abstract description 61
- 229960000946 dimetridazole Drugs 0.000 title claims abstract description 61
- 239000000843 powder Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract description 26
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 14
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims abstract description 14
- 229920003081 Povidone K 30 Polymers 0.000 claims abstract description 9
- 239000011265 semifinished product Substances 0.000 claims description 24
- 229920001983 poloxamer Polymers 0.000 claims description 23
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 18
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 16
- 229960001031 glucose Drugs 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 239000005030 aluminium foil Substances 0.000 claims description 12
- 238000007599 discharging Methods 0.000 claims description 12
- 238000007689 inspection Methods 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 12
- 238000000227 grinding Methods 0.000 claims description 7
- 230000009514 concussion Effects 0.000 claims description 6
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 abstract description 7
- 235000020188 drinking water Nutrition 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 3
- 238000009736 wetting Methods 0.000 abstract description 2
- 239000012052 hydrophilic carrier Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 abstract 1
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 229920001993 poloxamer 188 Polymers 0.000 abstract 1
- 229940044519 poloxamer 188 Drugs 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 13
- 239000000047 product Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 208000005448 Trichomonas Infections Diseases 0.000 description 2
- 206010044620 Trichomoniasis Diseases 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- -1 nitre azoles Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610529739.0A CN105919942B (zh) | 2016-07-07 | 2016-07-07 | 一种地美硝唑可溶性粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610529739.0A CN105919942B (zh) | 2016-07-07 | 2016-07-07 | 一种地美硝唑可溶性粉及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105919942A true CN105919942A (zh) | 2016-09-07 |
CN105919942B CN105919942B (zh) | 2019-05-03 |
Family
ID=56827583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610529739.0A Active CN105919942B (zh) | 2016-07-07 | 2016-07-07 | 一种地美硝唑可溶性粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105919942B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108553423A (zh) * | 2018-05-16 | 2018-09-21 | 厦门汇承科技有限公司 | 一种水溶性的兽用地美硝唑预混剂及其制备方法 |
CN109260158A (zh) * | 2018-09-28 | 2019-01-25 | 青岛康地恩动物药业有限公司 | 一种高水溶性高稳定性的地美硝唑预混剂 |
CN114601795A (zh) * | 2022-04-02 | 2022-06-10 | 江西利德菲生物药业有限公司 | 一种高稳定性的地美硝唑预混剂及其制备方法 |
CN117084984A (zh) * | 2023-10-08 | 2023-11-21 | 上海同仁药业股份有限公司 | 一种高效制备地美硝唑预混剂的方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309504A (zh) * | 2011-07-06 | 2012-01-11 | 天津生机集团股份有限公司 | 用于治疗鸡肠毒综合症的组合物及其制备方法 |
CN102988363A (zh) * | 2012-11-19 | 2013-03-27 | 河南新正好生物工程有限公司 | 一种治疗家禽腺胃炎和坏死性肠炎的药物及其制备方法 |
CN103417553A (zh) * | 2013-08-30 | 2013-12-04 | 天津生机集团股份有限公司 | 用于治疗母猪生殖系统感染的组合物及其制备方法 |
CN103432136A (zh) * | 2013-08-30 | 2013-12-11 | 天津生机集团股份有限公司 | 用于治疗鸡输卵管炎的组合物及其制备方法 |
CN104367553A (zh) * | 2014-11-26 | 2015-02-25 | 上海同仁药业有限公司 | 恩诺沙星可溶性粉剂及其制备方法 |
-
2016
- 2016-07-07 CN CN201610529739.0A patent/CN105919942B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309504A (zh) * | 2011-07-06 | 2012-01-11 | 天津生机集团股份有限公司 | 用于治疗鸡肠毒综合症的组合物及其制备方法 |
CN102988363A (zh) * | 2012-11-19 | 2013-03-27 | 河南新正好生物工程有限公司 | 一种治疗家禽腺胃炎和坏死性肠炎的药物及其制备方法 |
CN103417553A (zh) * | 2013-08-30 | 2013-12-04 | 天津生机集团股份有限公司 | 用于治疗母猪生殖系统感染的组合物及其制备方法 |
CN103432136A (zh) * | 2013-08-30 | 2013-12-11 | 天津生机集团股份有限公司 | 用于治疗鸡输卵管炎的组合物及其制备方法 |
CN104367553A (zh) * | 2014-11-26 | 2015-02-25 | 上海同仁药业有限公司 | 恩诺沙星可溶性粉剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
方亮: "《药剂学》", 31 March 2016, 中国医药科技出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108553423A (zh) * | 2018-05-16 | 2018-09-21 | 厦门汇承科技有限公司 | 一种水溶性的兽用地美硝唑预混剂及其制备方法 |
CN109260158A (zh) * | 2018-09-28 | 2019-01-25 | 青岛康地恩动物药业有限公司 | 一种高水溶性高稳定性的地美硝唑预混剂 |
CN114601795A (zh) * | 2022-04-02 | 2022-06-10 | 江西利德菲生物药业有限公司 | 一种高稳定性的地美硝唑预混剂及其制备方法 |
CN117084984A (zh) * | 2023-10-08 | 2023-11-21 | 上海同仁药业股份有限公司 | 一种高效制备地美硝唑预混剂的方法 |
CN117084984B (zh) * | 2023-10-08 | 2024-03-29 | 上海同仁药业股份有限公司 | 一种高效制备地美硝唑预混剂的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105919942B (zh) | 2019-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220125924A1 (en) | Granulated anthelmintic preparations and delivery systems | |
CN105919942A (zh) | 一种地美硝唑可溶性粉及其制备方法 | |
CN106176617A (zh) | 阿莫西林可溶性粉及其制备方法 | |
JP2018030873A (ja) | ランタン化合物を含むカプセル製剤及び粉末製剤 | |
US10258562B2 (en) | Effervescent tablet containing high level of aspirin | |
CN102772363B (zh) | 一种含泊那珠利的溶液剂及其制备方法 | |
CN102711761A (zh) | 溶出稳定化制剂 | |
CN109010320A (zh) | 一种双释型聚卡波非钙颗粒剂及制备方法和畜禽中的应用 | |
CA2978016C (en) | Monensin water dispersible granules by wet granulation | |
CN106214643A (zh) | 复方枸缘酸钠散及其制备方法 | |
CN105412132A (zh) | 复方伊维菌素缓释颗粒剂及其制备方法 | |
US20150104539A1 (en) | Citrated folic acid compositions and methods for delivering folic acid to usp dissolution specifications | |
Liu et al. | Preparation and Characterization of the Biological Compound Effervescent Granule of Calcium Acetate | |
CN105769787A (zh) | 一种格列美脲片的制备方法 | |
WO2013062425A1 (en) | Ionophore antibiotic veterinary composition and method of manufacture | |
CN106176831A (zh) | 一种复方氨基酸螯合钙胶囊及其制备方法 | |
CN108721245A (zh) | 一种肠道靶向缓释型氨基酸制剂及其制备方法 | |
NZ758849A (en) | Drenching platform or system, consumables thereof and related aspects | |
NZ758849B2 (en) | Drenching platform or system, consumables thereof and related aspects | |
JPS606614A (ja) | 下痢治療及び予防用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230531 Address after: No. 118-1, Jianshe Road, Guangde Economic Development Zone, Xuancheng City, Anhui Province, 242200 Patentee after: Ailimai (Anhui) Animal Pharmaceutical Co.,Ltd. Address before: No. 2 Fengdu Road, Fengdu Industrial Zone, Pingyao Town, Yuhang District, Hangzhou City, Zhejiang Province, 311115 Patentee before: HANGZHOU ANIMATE ANIMAL PHARMACEUTICAL CO.,LTD. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A soluble powder of dexamethasone and its preparation method Granted publication date: 20190503 Pledgee: Industrial and Commercial Bank of China Limited Guangde sub branch Pledgor: Ailimai (Anhui) Animal Pharmaceutical Co.,Ltd. Registration number: Y2024980002937 |